392 related articles for article (PubMed ID: 30710503)
1. The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout.
Szekanecz Z; Szamosi S; Kovács GE; Kocsis E; Benkő S
Arch Biochem Biophys; 2019 Jul; 670():82-93. PubMed ID: 30710503
[TBL] [Abstract][Full Text] [Related]
2. Lower Temperatures Exacerbate NLRP3 Inflammasome Activation by Promoting Monosodium Urate Crystallization, Causing Gout.
Ahn H; Lee G; Lee GS
Cells; 2021 Jul; 10(8):. PubMed ID: 34440688
[TBL] [Abstract][Full Text] [Related]
3. EPS8 regulates an NLRP3 inflammasome-independent caspase-1 activation pathway in monosodium urate crystal-treated RAW264.7 macrophages.
Chuang JP; Kao CY; Lee JC; Ling P; Maa MC; Leu TH
Biochem Biophys Res Commun; 2020 Sep; 530(3):487-493. PubMed ID: 32595041
[TBL] [Abstract][Full Text] [Related]
4. Beneficial Properties of Phytochemicals on NLRP3 Inflammasome-Mediated Gout and Complication.
Jhang JJ; Lin JH; Yen GC
J Agric Food Chem; 2018 Jan; 66(4):765-772. PubMed ID: 29293001
[TBL] [Abstract][Full Text] [Related]
5. Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout.
Lee HE; Yang G; Kim ND; Jeong S; Jung Y; Choi JY; Park HH; Lee JY
Sci Rep; 2016 Dec; 6():38622. PubMed ID: 27934918
[TBL] [Abstract][Full Text] [Related]
6. Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation.
Yang G; Yeon SH; Lee HE; Kang HC; Cho YY; Lee HS; Lee JY
Rheumatology (Oxford); 2018 Apr; 57(4):727-736. PubMed ID: 29340626
[TBL] [Abstract][Full Text] [Related]
7. 4-(2-(4-chlorophenyl)-1-((4-chlorophenyl)amino)ethyl)benzene-1, 3-diol is a potential agent for gout therapy as a dual inhibitor of XOD and NLRP3.
Zhou M; Li S; Song L; Hu Q; Liu W
Phytomedicine; 2018 Mar; 42():9-17. PubMed ID: 29655702
[TBL] [Abstract][Full Text] [Related]
8. NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout.
Amaral FA; Costa VV; Tavares LD; Sachs D; Coelho FM; Fagundes CT; Soriani FM; Silveira TN; Cunha LD; Zamboni DS; Quesniaux V; Peres RS; Cunha TM; Cunha FQ; Ryffel B; Souza DG; Teixeira MM
Arthritis Rheum; 2012 Feb; 64(2):474-84. PubMed ID: 21952942
[TBL] [Abstract][Full Text] [Related]
9. β-Hydroxybutyrate Deactivates Neutrophil NLRP3 Inflammasome to Relieve Gout Flares.
Goldberg EL; Asher JL; Molony RD; Shaw AC; Zeiss CJ; Wang C; Morozova-Roche LA; Herzog RI; Iwasaki A; Dixit VD
Cell Rep; 2017 Feb; 18(9):2077-2087. PubMed ID: 28249154
[TBL] [Abstract][Full Text] [Related]
10. Chaetocin attenuates gout in mice through inhibiting HIF-1α and NLRP3 inflammasome-dependent IL-1β secretion in macrophages.
Mian Wu ; Zhang M; Ma Y; Liu F; Chen S; Lu J; Chen H
Arch Biochem Biophys; 2019 Jul; 670():94-103. PubMed ID: 31255694
[TBL] [Abstract][Full Text] [Related]
11. Loganin Alleviates Gout Inflammation by Suppressing NLRP3 Inflammasome Activation and Mitochondrial Damage.
Choi N; Yang G; Jang JH; Kang HC; Cho YY; Lee HS; Lee JY
Molecules; 2021 Feb; 26(4):. PubMed ID: 33670601
[TBL] [Abstract][Full Text] [Related]
12. Overnutrition-induced gout: An immune response to NLRP3 inflammasome dysregulation by XOD activity increased in quail.
Wu H; Wang Y; Ren Z; Li Y; Huang J; Lin Z; Zhang B
Front Immunol; 2022; 13():1074867. PubMed ID: 36569836
[TBL] [Abstract][Full Text] [Related]
13. Management of Gout-associated MSU crystals-induced NLRP3 inflammasome activation by procyanidin B2: targeting IL-1β and Cathepsin B in macrophages.
Qiao CY; Li Y; Shang Y; Jiang M; Liu J; Zhan ZY; Ye H; Lin YC; Jiao JY; Sun RH; Zhang ZH; Piao MH; Wu YL; Nan JX; Lian LH
Inflammopharmacology; 2020 Dec; 28(6):1481-1493. PubMed ID: 33006110
[TBL] [Abstract][Full Text] [Related]
14. Secretion of IL-1β From Monocytes in Gout Is Redox Independent.
Alberts BM; Bruce C; Basnayake K; Ghezzi P; Davies KA; Mullen LM
Front Immunol; 2019; 10():70. PubMed ID: 30761138
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin-3-Gallate Prevents Acute Gout by Suppressing NLRP3 Inflammasome Activation and Mitochondrial DNA Synthesis.
Lee HE; Yang G; Park YB; Kang HC; Cho YY; Lee HS; Lee JY
Molecules; 2019 Jun; 24(11):. PubMed ID: 31174271
[TBL] [Abstract][Full Text] [Related]
16. Precipitation of Soluble Uric Acid Is Necessary for
Alberts BM; Barber JS; Sacre SM; Davies KA; Ghezzi P; Mullen LM
J Rheumatol; 2019 Sep; 46(9):1141-1150. PubMed ID: 30824640
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of mitochondrial pyruvate carrier promotes NLRP3 inflammasome activation and gout development via metabolic reprogramming.
Chen LC; Chen YJ; Lin HA; Chien WC; Tsai KJ; Chung CH; Wang JY; Chen CC; Liao NS; Shih CT; Lin YY; Huang CN; Ojcius DM; Huang KY; Lin HC
Immunology; 2023 Jul; 169(3):271-291. PubMed ID: 36708143
[TBL] [Abstract][Full Text] [Related]
18. NLRP3 inflammasome inhibitor cucurbitacin B suppresses gout arthritis in mice.
Xue Y; Li R; Fang P; Ye ZQ; Zhao Y; Zhou Y; Zhang KQ; Li L
J Mol Endocrinol; 2021 Jun; 67(2):27-40. PubMed ID: 34047713
[TBL] [Abstract][Full Text] [Related]
19. Rutin ameliorates gout via reducing XOD activity, inhibiting ROS production and NLRP3 inflammasome activation in quail.
Wu H; Wang Y; Huang J; Li Y; Lin Z; Zhang B
Biomed Pharmacother; 2023 Feb; 158():114175. PubMed ID: 36587556
[TBL] [Abstract][Full Text] [Related]
20. Rhein, An Anthraquinone Drug, Suppresses the NLRP3 Inflammasome and Macrophage Activation in Urate Crystal-Induced Gouty Inflammation.
Chang WC; Chu MT; Hsu CY; Wu YJ; Lee JY; Chen TJ; Chung WH; Chen DY; Hung SI
Am J Chin Med; 2019; 47(1):135-151. PubMed ID: 30612459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
